These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34988814)

  • 21. Using 10-K text to gauge COVID-related corporate disclosure.
    Dutta S; Kumar A; Pant P; Walsh C; Dutta M
    PLoS One; 2023; 18(3):e0283138. PubMed ID: 36947527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adopting Occupational Health and Safety Management Standards: The Impact on Financial Performance in Pharmaceutical Firms in China.
    Yang M; Maresova P
    Risk Manag Healthc Policy; 2020; 13():1477-1487. PubMed ID: 32982506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does it pay to go green? The environmental innovation effect on corporate financial performance.
    Farza K; Ftiti Z; Hlioui Z; Louhichi W; Omri A
    J Environ Manage; 2021 Dec; 300():113695. PubMed ID: 34649325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Venture Capital on Enterprise Benefit According to the Heterogeneity of Human Capital of Entrepreneur.
    Jin X; Zheng P; Zhong Z; Cao Y
    Front Psychol; 2020; 11():1558. PubMed ID: 32754091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are circular economy strategies economically successful? Evidence from a longitudinal panel.
    Palea V; Santhià C; Miazza A
    J Environ Manage; 2023 Jul; 337():117726. PubMed ID: 36933534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical regulation in Europe and its impact on corporate R&D.
    Eger S; Mahlich JC
    Health Econ Rev; 2014 Dec; 4(1):23. PubMed ID: 26208924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shareholder personal risk and firm risk: An empirical analysis of share pledges and firm debt policies.
    Xia J; Wu Z; Zhang R; Chen X; Zhang R
    Front Psychol; 2022; 13():1010162. PubMed ID: 36467181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of corporate environmental responsibility on financial performance-based on Chinese listed companies.
    Liu Y; Xi B; Wang G
    Environ Sci Pollut Res Int; 2021 Feb; 28(7):7840-7853. PubMed ID: 33040290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nexus between corporate environment, social, and governance performance and cost of capital: evidence from top global tech leaders.
    Nazir M; Akbar M; Akbar A; Poulovo P; Hussain A; Qureshi MA
    Environ Sci Pollut Res Int; 2022 Mar; 29(15):22623-22636. PubMed ID: 34791632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Interactions of Absorptive Capacity, Buffer Inventory, and Toxic Emissions on Firm Value.
    Yiu LMD; Wu KYK
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33670749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the green credit policy affect the scale of corporate debt financing? Evidence from listed companies in heavy pollution industries in China.
    Peng B; Yan W; Elahi E; Wan A
    Environ Sci Pollut Res Int; 2022 Jan; 29(1):755-767. PubMed ID: 34341926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cost-benefit analysis under back propagation neural network on financial benefit evaluation of investment projects.
    Zhong Y; Wu X
    PLoS One; 2020; 15(3):e0229739. PubMed ID: 32134951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does intangible assets affect the financial performance and policy of commercial banks' in the emerging market?
    Abebe Zelalem B; Ali Abebe A
    PLoS One; 2022; 17(8):e0272018. PubMed ID: 36006901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moderating role of financial ratios in corporate social responsibility disclosure and firm value.
    Naseem MA; Lin J; Rehman RU; Ahmad MI; Ali R
    PLoS One; 2019; 14(4):e0215430. PubMed ID: 30998740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nexus between corporate social responsibility and financial and non-financial sectors' performance: a non-linear and disaggregated approach.
    Shabbir MS; Aslam E; Irshad A; Bilal K; Aziz S; Abbasi BA; Zia S
    Environ Sci Pollut Res Int; 2020 Nov; 27(31):39164-39179. PubMed ID: 32642899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term and short-term effects of green strategy on corporate performance: evidence from Chinese listed companies.
    Yu W; Jin X
    Environ Sci Pollut Res Int; 2022 Apr; 29(16):24112-24130. PubMed ID: 34822093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impacts of carbon emissions and voluntary carbon disclosure on firm value.
    Sun ZY; Wang SN; Li D
    Environ Sci Pollut Res Int; 2022 Aug; 29(40):60189-60197. PubMed ID: 35416581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How much cash does your company need?
    Passov R
    Harv Bus Rev; 2003 Nov; 81(11):119-22, 124-6, 128, 140. PubMed ID: 14619157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does CSR affect the cost of equity capital: Empirical evidence from the targeted poverty alleviation of listed companies in China.
    Yi Y; Xie B; Zhou L; Wei Y
    PLoS One; 2020; 15(2):e0227952. PubMed ID: 32032381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naive independent directors, corporate governance and firm performance.
    Chen G; Chen X; Wan P
    Front Psychol; 2022; 13():984661. PubMed ID: 36118473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.